Skip to main content
. 2007;6(4):132–140. doi: 10.1016/j.jcme.2007.10.001

Table 2.

Data from the first questionnaire (UDI + IIQ)

Group n At Baseline After 15 Treatments 30 d After the 15th Treatment 6 mo After the Last Treatment
Experimental 24 23.3 (10.7) 10.2 (8.4) 6.9 (4.8) 11.3 (11.1)
Control 9 25.3 (10.7) 22.2 (11.8)
Crossover 8 25.3 (13.2) 21.91 (13.6) 19.9 (13.6) 20.41 (10.9)

Numbers inside parentheses indicate the standard deviation.